دور البروتين الدهني في الدم أ والبروتين الدهني منخفض الكثافة والكوليسترول كعلامات لاعتلال الشبكية التكاثري وغير التكاثري لدى المرضى المصابين بداء السكري من النوع الثاني

1. Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nature Reviews Endocrinology. 2021;17:195-206. https://doi.org/10.1038/s41574-020-00451-4.

2. Kropp M, Golubnitschaja O, Mazurakova A, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation. EPMA Journal. 2023;14:21-42. https://doi.org/10.1007/s13167-023-00314-

3. Zhou J, Chen B. Retinal cell damage in diabetic retinopathy. Cells. 2023;12(9):1342. https://doi.org/10.3390/cells12091342.

4. Albadr A, Haddad NS. Pancreatic Stone Protein/regenerating Protein (PSP/reg) as a Biochemical Marker for prediction of Microvascular Complications of Type 2 Diabetes Mellitus. KCMJ. 2023;19(2):196-201. https://doi.org/10.47723/kcmj.v19i2.966.

5. Szczechla M, Balewska A, Naskręt D, Zozulińska-Ziółkiewicz D, Uruska A. Molecular Changes in Cells of Patients with Type 2 Diabetes Mellitus Depending on Changes in Glycemia Level in the Context of Lifestyle—An Overview of the Latest Scientific Discoveries. CIMBiology. 2023;45(3):1961-81. https://doi.org/10.3390/cimb45030126.

6. AlKenany Q, Rasheed MK, AlKazraj KA. The Predictive Role of Osteopontin Level in Patients with Type 2 Diabetes Mellitus without Fatty Liver Disease. JFacMedBaghdad. 2024;66(1):93-8. https://doi.org/10.32007/jfacmedbagdad.6612182

7. Al-Yassin HD. Correlation of Serum levels of Chromium, Copper, and Manganese with the Glucose levels in Type 2 Diabetes Mellitus in Iraq. JFacMedBaghdad. 2023;65(4). https://doi.org/10.32007/jfacmedbagdad.2126

8. Taha BE, Majeed MJ. Estimation of Insulin Resistance in Obese Adults in Baghdad. JFacMed Baghdad. 2023;65(4). https://doi.org/10.32007/jfacmedbagdad.2118.

9. Liu Z, Shao M, Ren J, Qiu Y, Li S, Cao W. Association between increased lipid profiles and risk of diabetic retinopathy in a population-based case-control study. JIR. 2022;15:3433-46. https://doi.org/10.2147/JIR.S361613.

10. Julve J, Rossell J, Correig E, et al. Predictive value of the advanced lipoprotein profile and glycated proteins on diabetic retinopathy. Nutrients. 2022;14(19):3932. https://doi.org/10.3390/nu14193932.

11. Hirano T, Hayashi T, Sugita H, et al. Prospective randomized comparative study of the effect of pemafibrate add‐on or double statin dose on small dense low‐density lipoprotein‐cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy. J Diabetes Investig. 2023;14(12):1401-11. https://doi.org/10.1111/jdi.14076

12. Sun C, Chen Q, Zhang X, et al. Peripheral Neuropathy Is Associated With High Serum Levels of Small Dense Low-density Lipoprotein-cholesterol in Patients With Type 2 Diabetes Mellitus. 2021.

13. Otrante A, Bounafaa A, Berrougui H, Essamadi A-K, Nguyen M, Fülöp T, et al. Small Dense LDL Level and LDL/HDL Distribution in Acute Coronary Syndrome Patients. Biomedicines. 2023;11(4):1198. https://doi.org/10.3390/biomedicines11041198

14. Płaczkowska S, Sołkiewicz K, Bednarz-Misa I, Kratz EM. Atherogenic plasma index or non-high-density lipoproteins as markers best reflecting age-related high concentrations of small dense low-density lipoproteins. IJMS. 2022;23(9):5089. https://doi.org/10.3390/ijms23095089

15. Nakayama A, Morita H, Sato T, et al. Small dense low-density lipoprotein cholesterol is a potential marker for predicting laser treatment for retinopathy in diabetic patients. JAT. 2022;29(5):678-91. https://doi.org/10.5551/jat.62889

16. Atchison E, Barkmeier A. The role of systemic risk factors in diabetic retinopathy. Current Ophthalmology Reports. 2016;4:84-9. https://doi.org/10.1007/s40135-016-0098-8.

17. Soedarman S, Kurnia KH, Prasetya ADB, Sasongko MB. Cholesterols, apolipoproteins, and their associations with the presence and severity of diabetic retinopathy: a systematic review. Vision. 2022;6(4):77. https://doi.org/10.3390/vision6040077

18.Bryl A, Mrugacz M, Falkowski M, Zorena K. The Effect of Hyperlipidemia on the Course of Diabetic Retinopathy—Literature Review. JCM. 2022;11(10):2761. https://doi.org/10.3390/jcm11102761

19. Hukportie DN, Li FR, Zhou R, et al. Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis. J Diabetes. 2022;14(6):365-76. https://doi.org/10.1111/1753-0407.13273

20. Li Z, Yuan Y, Qi Q, Wang Q, Feng L. Relationship between dyslipidemia and diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Syst Rev. 2023; 12:148. https://doi.org/10.1186/s13643-023-02321-2

21. Romero-Aroca P, Verges R, Pascual-Fontanilles J, et al. Effect of Lipids on Diabetic Retinopathy in a Large Cohort of Diabetic Patients after 10 Years of Follow-Up. JCM. 2023;12(20):6674. https://doi.org/10.3390/jcm12206674

22. Chou Y, Ma J, Su X, Zhong Y. Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy. Lipids Health Dis. 2020; 19:241. https://doi.org/10.1186/s12944-020-01415-3